Latest prescription data shows consumption of psychiatric drugs continues to soar

The latest prescription figures from the Health and Social Care Information Centre show that the UK is in the midst of a psychiatric drug epidemic.  Over 57m prescriptions for antidepressants were issued in England in 2014, enough for one for every man, woman and child.  This represents a 7.5% increase since 2013, and over 500% […]

Continue Reading 5

Allen Frances, editor of DSM-IV, developed Risperdal guidelines ‘in disregard of… conflict of interest’

Dr Paula Caplan, associate of the DuBois Research Institute at Harvard University, has written an article exposing historical ties between Dr Allen Frances, lead editor of DSM-IV, and Janssen Pharmaceuticals, a Johnson & Johnson subsidiary and the makers of Risperdal, a second generation antipsychotic. Caplan cites a 2010 court document written by Dr David J Rothman, a […]

Continue Reading 1

Maudsley Debate: long-term use of psychiatric drugs is causing more harm than good?

Following its launch last year and the subsequent criticism of its position by prominent psychiatrists in the The Times and The Lancet Psychiatry, CEP responded by issuing a challenge to its critics to engage in an open, public debate on psychiatric drug harm. CEP is therefore pleased to announce that Kings College London has agreed to host a […]

Continue Reading 9

Peter Gøtzsche’s latest book ‘Deadly Medicines and Organised Crime: How Big Pharma has Corrupted Healthcare’ wins first prize in BMA book awards 2014

Professor Peter Gøtzsche has won first prize in the 2014 BMA book awards in the Basis of Medicine Category with his most recent book, ‘Deadly Medicines and Organised Crime: How Big Pharma Has Corrupted Healthcare’, published by Radcliffe Publishing.  Peter is Director of the Nordic Cochrane Centre and a member of CEP. The BMA reviewer commented as […]

Continue Reading 3

Full text of CEP members’ letter to The Lancet Psychiatry in response to article by Nutt et al

David Nutt and colleagues1 represent a brand of psychiatry that wishes to keep its eyes firmly shut when evidence of harms and lack of effectiveness of favoured biological treatments are found. It is therefore unsurprising they take issue with the Council for Evidence-based Psychiatry for publicising evidence that rarely gets discussed; evidence that would enable people […]

Continue Reading 4

CEP members respond to David Nutt and colleagues in letter to The Lancet Psychiatry

The Lancet Psychiatry today published a letter from members of the Council for Evidence-based Psychiatry.  The letter is a response to a previous article in The Lancet Psychiatry entitled “Attacks on antidepressants: signs of deep-seated stigma?” which was contributed by Professor David Nutt, Professor Guy Goodwin and others. CEP’s letter can be seen here (no […]

Continue Reading 0

Peter Gøtzsche responds to criticism from Nutt et al in The Lancet

Professor Peter Gøtzsche has today published an article in The Lancet entitled: ‘Why I think antidepressants cause more harm than good’. It was written in response to an earlier piece by Professor David Nutt, Professor Guy Goodwin and others under the heading: ‘Attacks on antidepressants: signs of deep-seated stigma?’ Gøtzsche’s article can be read here: http://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(14)70280-9/fulltext?_eventId=login […]

Continue Reading 4

James Davies debates Simon Wessely today on BBC Radio 4 PM news programme

The BBC’s flagship afternoon news programme ‘PM’ on Radio 4 today includes a debate between Dr James Davies and Professor Sir Simon Wessely, the new President of the Royal College of Psychiatrists, regarding oversubscribing of antidepressants and the need for greater transparency within UK psychiatry. The segment starts at 39 mins 20 secs at the […]

Continue Reading 4

Peter Gøtzsche responds to BMJ article challenging CEP’s overprescribing figures

Dr Margaret McCartney has today published an article in the BMJ entitled ‘Overprescribing antidepressants: where’s the evidence?’ which casts doubt on the validity of figures used by CEP to highlight the growth of prescribing of antidepressants. “CEP said that antidepressant use had increased by 92% in England since 20035; however, it cited the Health and […]

Continue Reading 3

Powered by WordPress. Designed by Woo Themes